Webcast Info
The webcast could be accessed right here or by visiting the Buyers part of the Firm’s web site at www.talphera.com and clicking on the webcast hyperlink posted inside Buyers/Information & Occasions/Upcoming Occasions part. The webcast will embody a slide presentation and a replay will probably be accessible on the Talphera web site for 90 days following the occasion.
Convention Name Info
Buyers who want to take part within the convention name could achieve this by dialing 1-800-836-8184 for North American callers, or 1-646-357-8785 (toll applies) for worldwide callers exterior of
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical firm centered on the event and commercialization of revolutionary therapies to be used in medically supervised settings. Talphera’s lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is at the moment being studied underneath an investigational gadget exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has acquired Breakthrough Gadget Designation standing from the U.S. Meals and Drug Administration (FDA). Talphera can also be creating two pre-filled syringes in-licensed from its associate Aguettant: Fedsyra™, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.
This launch is meant for buyers solely. For added details about Talphera, please go to www.talphera.com.
